175 related articles for article (PubMed ID: 1361736)
1. Effect of a new non-steroidal anti-inflammatory combination of a histamine H2 antagonist and indomethacin on gastroduodenal mucosal membrane in rat.
Segawa Y; Omata T; Abe T; Tsuzuike N; Itokazu Y; Yoshida K; Ueda I
Arzneimittelforschung; 1992 Oct; 42(10):1232-5. PubMed ID: 1361736
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory, analgesic, and antipyretic effects and gastrointestinal toxicity of the new anti-inflammatory drug N-(3-[3-(piperidinylmethyl)phenoxy]propyl)-carbamoylmethylthio ]ethyl 1-(p-chlorobenzoyl) 5-methoxy-2-methyl-3-indolylacetate.
Segawa Y; Ohya O; Abe T; Omata T; Tsuzuike N; Itokazu Y; Yoshida K; Tagashira E; Ueda I
Arzneimittelforschung; 1992 Jul; 42(7):954-8. PubMed ID: 1418061
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
Scarpignato C; Pelosini I
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
[TBL] [Abstract][Full Text] [Related]
4. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Amagase K; Kato S; Yamamoto H; Okabe S
Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
[TBL] [Abstract][Full Text] [Related]
5. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of an anti-inflammatory-histamine H2 antagonist drug complex on gastric erosions in the rat.
Imai T; Fukuhara A; Ueda I; Otagiri M
J Pharmacol Exp Ther; 1993 Apr; 265(1):328-33. PubMed ID: 8097246
[TBL] [Abstract][Full Text] [Related]
7. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
Agrawal NM; Saggioro A
J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
[TBL] [Abstract][Full Text] [Related]
8. Effect of NS-398, a new nonsteroidal anti-inflammatory agent, on gastric ulceration and acid secretion in rats.
Arai I; Hamasaka Y; Futaki N; Takahashi S; Yoshikawa K; Higuchi S; Otomo S
Res Commun Chem Pathol Pharmacol; 1993 Sep; 81(3):259-70. PubMed ID: 8235061
[TBL] [Abstract][Full Text] [Related]
9. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
11. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
Puscas I; Puscas C; Coltau M; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory and gastro sparing activity of some new indomethacin derivatives.
Amir M; Kumar S
Arch Pharm (Weinheim); 2005 Jan; 338(1):24-31. PubMed ID: 15674801
[TBL] [Abstract][Full Text] [Related]
14. Studies on the gastric tolerability of the new non-steroidal anti-inflammatory drug amtolmetin guacyl.
Tubaro E; Belogi L; Mezzadri CM; Ruco L; Stopacciaro A
Arzneimittelforschung; 1995 Dec; 45(12):1298-302. PubMed ID: 8595088
[TBL] [Abstract][Full Text] [Related]
15. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.
Agrawal NM; Dajani EZ
Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801
[TBL] [Abstract][Full Text] [Related]
16. Ulcerogenicity and effect on inhibition of prostaglandin generation of indometacin farnesil, a prodrug of indomethacin, in rat gastric mucosa: comparison with indomethacin or loxoprofen.
Arakawa T; Fukuda T; Nakagawa K; Higuchi K; Watanabe T; Tominaga K; Kobayashi K
Drugs Exp Clin Res; 1995; 21(3):85-8. PubMed ID: 7555616
[TBL] [Abstract][Full Text] [Related]
17. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1, interleukin-4 and nitric oxide synthase modulators of gastric mucosal injury by indomethacin: effect of antiulcer agents.
Slomiany BL; Piotrowski J; Slomiany A
J Physiol Pharmacol; 1999 Jun; 50(2):197-210. PubMed ID: 10424717
[TBL] [Abstract][Full Text] [Related]
19. Contribution to safe anti-inflammatory therapy with indomethacin.
Bauerová K; Nosál'ová V; Mihalová D; Navarová J
Cent Eur J Public Health; 2004 Mar; 12 Suppl():S8-10. PubMed ID: 15141962
[TBL] [Abstract][Full Text] [Related]
20. Effect of H2-receptor antagonists on indomethacin-induced lysosomal enzyme release from rat gastric mucosa.
Navarová J; Nosálová V
Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):119-24. PubMed ID: 7911862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
